Helius oil to be tested in NZ sleep trial by Adam Sheldon October 20, 2026October 20, 2026 Helius Therapeutics will supply its cannabinoid oil for an independent Phase 2 clinical trial investigating whether […]
Rua launches NZ$2.8m capital raise in bid to continue revenue growth by Steve Jones September 25, 2026September 25, 2026
It’s professionals, not products who will write the next chapter of medicinal cannabis by Dr Davin Gunn June 22, 2026June 22, 2026
Ora Pharm buys key Helius Therapeutics assets in major NZ deal by Adam Sheldon May 13, 2026May 13, 2026
ECS bucks market downturn with third consecutive positive quarter by Adam Sheldon April 28, 2026April 28, 2026
We just couldn’t grow fast enough, Helius CEO reveals amid warning for firms to be ‘realistic’ by Adam Sheldon March 26, 2026March 26, 2026
Puro cannabis beats wine to win Marlborough’s top business award by Adam Sheldon November 25, 2025February 21, 2026
New data: Australia and NZ markets maturing amid regulatory changes by Adam Sheldon November 5, 2025February 21, 2026
